Octreotide Infusion for the Treatment of Congenital Chylothorax

Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have b...

Full description

Saved in:
Bibliographic Details
Main Authors: Sumayyah Ahmed Nezar Kobeisy, Abdulaziz Alkhotani, Mohammed M. Barzanji
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Pediatrics
Online Access:http://dx.doi.org/10.1155/2020/8890860
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850159990385410048
author Sumayyah Ahmed Nezar Kobeisy
Abdulaziz Alkhotani
Mohammed M. Barzanji
author_facet Sumayyah Ahmed Nezar Kobeisy
Abdulaziz Alkhotani
Mohammed M. Barzanji
author_sort Sumayyah Ahmed Nezar Kobeisy
collection DOAJ
description Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion.
format Article
id doaj-art-b29af65ce6c84553a36ea54cfcf14a53
institution OA Journals
issn 2090-6803
2090-6811
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Pediatrics
spelling doaj-art-b29af65ce6c84553a36ea54cfcf14a532025-08-20T02:23:18ZengWileyCase Reports in Pediatrics2090-68032090-68112020-01-01202010.1155/2020/88908608890860Octreotide Infusion for the Treatment of Congenital ChylothoraxSumayyah Ahmed Nezar Kobeisy0Abdulaziz Alkhotani1Mohammed M. Barzanji2Dr. Soliman Fakeeh Hospital, Jeddah, Saudi ArabiaDr. Soliman Fakeeh Hospital, Jeddah, Saudi ArabiaDr. Soliman Fakeeh Hospital, Jeddah, Saudi ArabiaCongenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion.http://dx.doi.org/10.1155/2020/8890860
spellingShingle Sumayyah Ahmed Nezar Kobeisy
Abdulaziz Alkhotani
Mohammed M. Barzanji
Octreotide Infusion for the Treatment of Congenital Chylothorax
Case Reports in Pediatrics
title Octreotide Infusion for the Treatment of Congenital Chylothorax
title_full Octreotide Infusion for the Treatment of Congenital Chylothorax
title_fullStr Octreotide Infusion for the Treatment of Congenital Chylothorax
title_full_unstemmed Octreotide Infusion for the Treatment of Congenital Chylothorax
title_short Octreotide Infusion for the Treatment of Congenital Chylothorax
title_sort octreotide infusion for the treatment of congenital chylothorax
url http://dx.doi.org/10.1155/2020/8890860
work_keys_str_mv AT sumayyahahmednezarkobeisy octreotideinfusionforthetreatmentofcongenitalchylothorax
AT abdulazizalkhotani octreotideinfusionforthetreatmentofcongenitalchylothorax
AT mohammedmbarzanji octreotideinfusionforthetreatmentofcongenitalchylothorax